Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-fluorouracil-based chemotherapy? (multiple letter)

Oncologist

Volumn 9, Issue 5, 2004, Pages 594-596

  Magagnoli, Massimo ^a   Castagna, Luca ^a   Masci, Giovanna ^a   Santoro, Armando ^a   Kuter, David J ^b,c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; WARFARIN;

CANCER CHEMOTHERAPY; CATHETERIZATION; CENTRAL VENOUS CATHETER; HUMAN; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; THROMBOSIS;

ANTICOAGULANTS; ANTIMETABOLITES, ANTINEOPLASTIC; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FLUOROURACIL; HUMANS; INTERNATIONAL NORMALIZED RATIO; NEOPLASMS; ORGANOPLATINUM COMPOUNDS; THROMBOSIS; WARFARIN;

EID: 4944264432     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.9-5-594     Document Type: Letter

References (0)